@natalieksafa
1 post audited · 6 claims analysed
Science evidence grade
Based on 6 claims across 1 audit
4
Supported
67%
2
Overstated
33%
0
Misleading
0%
0
No Evidence
0%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @natalieksafa claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
67%
4 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
33%
2 claims
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(1 post)
“Peptides for women HYPE or HELPFUL #peptides #peptideskincare #kettlebell #fitness #kettlebellworkout #workout #crossfit #gym #training #kettlebells #kettlebelltraining #personaltrainer”
Claim 1 (peptides = amino acids linked by peptide bonds) is **supported** — it is established biochemistry. Claims 2–6, however, lack direct evidence: no human clinical trials or peer-reviewed abstracts are provided to substantiate the specific claims about CJC-1295, ipamorelin, and their effects on GH release, muscle hypertrophy, fat metabolism, or training recovery. PeptIQ's internal glossary and peptide profiles suggest mechanistic plausibility for GH-secretagogue activity, but without access to the cited Phase 2 trial abstracts or peer-reviewed literature on these specific outcomes, the scientific standing remains unverified. To upgrade these verdicts, direct study abstracts or trial results demonstrating human efficacy would need to be provided and analyzed.
Audit another post from @natalieksafa
Paste their social post link to add a new audit